AGENDA

Medical Conference Agenda
   
      10:00am-10:50am
      
        Registration
       
      10:50am-11:00am
      
        Welcome
       
      11:00am-12:00pm
      
          Track 1: Oncology Provider Track
         
          Challenging Cases
         
          Betty Fan, DO; Nora Jaskowiak, MD; Fred Howard, MD; Olwen Hahn, MD
         
          Rita Nanda, MD
         
          Track 2: Primary Care Provider Track
         
          Toxicities of Breast Cancer Therapy
         
          Joly Raju, NP; Amanda Krug, PA; Hannah Gielczyk, NP; Heng Yang, PharmD
         
          Lauren Olalde, RN
         
      12:00pm-1:00pm
      
        Lunch and Exhibits
       
      1:00pm-2:00pm
      
        KEYNOTE LECTURE
       
        The Emerging Role of ctDNA in Breast Cancer
       
        Daniel Stover, MD
       
      2:00pm-3:00pm
      
          Track 1: Oncology Provider Track
         
          Breast Cancer Surgery in 2026: Role of de-escalation and multidisciplinary decision-making
         
          Sarah Shubeck, MD, MS
         
          Updates and Advancements in Breast Reconstruction
         
          Maureen Beederman, MD
         
          Radiation Oncology Updates
         
          Steven Chmura, MD, PhD
         
          Q&A
         
          Track 2: Primary Care Provider Track
         
          Hormone Receptor-Positive Breast Cancer: An Overview of Current Care and Recent Updates
         
          Sarah Poland, MD
         
          Caring for Patients With HER2-Positive Breast Cancer
         
          Frederick Howard, MD
         
          Triple-Negative Breast Cancer: Essentials for Primary Care Providers in 2026
         
          Maeve Hennessy, MD
         
          Q&A
         
      3:00pm-4:00pm
      
          Track 1: Oncology Provider Track
         
          Hormone Receptor-Positive Breast Cancer: Highlights That Are Shaping Practice
         
          Sarah Poland, MD
         
          Evolving Treatment Landscape of HER2+ Breast Cancer in 2026
         
          Frederick Howard, MD
         
          Triple-Negative Breast Cancer: Updates, Evolving Treatments, and Future Directions
         
          Maeve Hennessy, MD
         
          Q&A
         
          Track 2: Primary Care Provider Track
         
          Breast Cancer Surgery in 2026
         
          Sarah Shubeck, MD
         
          Breast Reconstruction 101
         
          Maureen Beederman, MD
         
          The New Era of Breast Radiation: Fast, Focused, and Patient-Centered
         
          Steven Chmura, MD, PhD
         
          Q&A
         
      4:00pm-4:15pm
      
        Refreshment Break
       
      4:15pm-5:30pm
      
        SUBSPECIALTY CARE OF BREAST CANCER PATIENTS
       
        Management of Sexual Side Effects of Breast Cancer Therapy
       
        Maryam Siddiqui, MD
       
        Hair Loss and Breast Cancer Therapy
       
        Victoria Barbosa, MD
       
        Lymphedema Management
       
        Scott Grumeretz, PT, DPT, CLT
       
        Genetic Testing Considerations in Breast Cancer Patients
       
        Feighanne Hathaway, MS, CGC
       
        Q&A
       
      5:30pm-5:35pm
      
        Concluding Remarks